Among 85 NSCLC patients with EGFR mutations treated with ICIs, there were 45 patients with exon 19 deletions, 33 patients with L858R mutations, and seven patients with uncommon EGFR mutations. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.